Kevin M. Fussell, M.D.
NPI 1164404901ActiveIndividual· Internal Medicine, Pulmonary Disease· Encinitas, CA
Internal Medicine, Pulmonary Disease (M.D.) in Encinitas, California, trained at Vanderbilt University School of Medicine (class of 1997). Their prescriptions cost Medicare Part D more than their services did: $720,857 for 1,477 claims, against $180,434 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 14 companies reporting payments in 2025, $238,714 in all, mostly speaking and faculty fees.
Overview
| NPI | 1164404901 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Nov 17, 2005 |
| Last updated in NPPES | Jul 24, 2025 |
| Certified by provider | Jul 24, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Pulmonary Disease Primary | 207RP1001X | 0101269338 | VA |
| Internal Medicine, Critical Care Medicine | 207RC0200X | C172323 | CA |
| Internal Medicine, Critical Care Medicine | 207RC0200X | 067298 | GA |
| Internal Medicine, Critical Care Medicine | 207RC0200X | 0101269338 | VA |
| Internal Medicine, Pulmonary Disease | 207RP1001X | C172323 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pulmonary Disease (CA) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 740 |
|---|---|
| Services billed | 1,785 across 30 procedure codes |
| Paid by Medicare | $180,434 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,477 · 1,749 30-day fills |
|---|---|
| Patients | 318 |
| Total drug cost | $720,857 |
| Generic share | 45% of claims |
Education and affiliations
| Medical school | Vanderbilt University School of Medicine |
|---|---|
| Graduation year | 1997 |
| Medicare specialty | Pulmonary Disease |
| Secondary specialties | Critical Care (Intensivists) |
| Telehealth | Offers telehealth |
Medical groups
- Acute Care Associates IncEncinitas, CA · 29 clinicians
- Scott A Eisman MD IncVista, CA · 13 clinicians
Hospital affiliations
- Scripps Memorial Hospital - EncinitasEncinitas, CA
- Scripps Memorial Hospital la JollaLa Jolla, CA
Industry payments (Open Payments)
- 2025$238,714 · 332 payments from 14 companies
- 2024$211,123 · 294 payments from 16 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $150,245 | 187 |
| Genzyme Corporation | $58,248 | 54 |
| Regeneron Healthcare Solutions, Inc. | $29,321 | 44 |
| Glaxosmithkline, LLC. | $238.60 | 16 |
| Pfizer Inc. | $133.77 | 6 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$204,059 · 87 payments
- Travel and Lodging$20,396 · 77 payments
- Consulting Fee$7,216 · 7 payments
- Food and Beverage$7,026 · 160 payments
- Education$17.38 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Pulmonary Disease providers in Encinitas
- 1841387214
- 1801184031
- 1407043847
- 1821188384
- 1477524403
- 1275511420
- 1720052988
- 1790769131
- 1356838957
- 1790342699
- 1881694891
- 1154520864
All Internal Medicine, Pulmonary Disease providers in California →